Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreatoblastoma.

Muhammad Wasif Saif1

  • 1Yale University School of Medicine, New Haven, CT 06520, USA. wasif.saif@yale.edu

JOP : Journal of the Pancreas
|January 18, 2007
PubMed
Summary
This summary is machine-generated.

Pancreatoblastoma (PB) is a rare childhood pancreatic tumor. Complete surgical resection offers a good prognosis, emphasizing early detection and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staged approach to overcome hyperbilirubinemia: tailored chemotherapy in liver metastases-a case report.

Journal of gastrointestinal oncology·2026
Same author

An overview of KRAS-targeting therapies for colorectal cancer in phase I and II development.

Expert opinion on investigational drugs·2026
Same author

PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer.

bioRxiv : the preprint server for biology·2025
Same author

Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma.

bioRxiv : the preprint server for biology·2025
Same author

An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors.

International journal of molecular sciences·2025
Same author

XPO1 inhibition in KRAS-mutant cancers: time for clinical trials but how?

Translational lung cancer research·2025
Same journal

Bridging the Gap in Pancreatic Imaging: A New Era of AI-Powered Precision.

JOP : Journal of the pancreas·2025
Same journal

From Screening to Treatment of Pancreatic Cancer: A Comprehensive Review.

JOP : Journal of the pancreas·2021
Same journal

Survival Benefits and Disparities in Adjuvant Radiation Therapy for Patients with Pancreatic Cancer.

JOP : Journal of the pancreas·2021
Same journal

Is There any Survival Benefit of Maintenance Chemotherapy Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer Patients with Post-Surgery Elevated CA 19-9?

JOP : Journal of the pancreas·2020
Same journal

New Developments in the Treatment of Pancreatic Cancer: Highlights from the 44th ASCO Annual Virtual Meeting, May 29-31, 2020.

JOP : Journal of the pancreas·2020
Same journal

Management of Pancreatic Cancer During COVID-19 Pandemic: To Treat or Not to Treat?

JOP : Journal of the pancreas·2020
See all related articles

Area of Science:

  • Pediatric Oncology
  • Gastrointestinal Pathology

Background:

  • Pancreatoblastoma (PB) is an extremely rare pancreatic neoplasm, primarily affecting children but also occurring in adults.
  • While less aggressive in younger patients, PB often presents late with abdominal pain and palpable masses.

Purpose of the Study:

  • To review the clinical presentation, etiology, diagnosis, treatment, and prognosis of Pancreatoblastoma.
  • To highlight the importance of early detection and proper management of this rare pancreatic tumor.

Main Methods:

  • Literature review of Pancreatoblastoma cases.
  • Analysis of clinical presentation, histological findings, and diagnostic modalities.
  • Evaluation of treatment strategies and patient outcomes.

Main Results:

Related Experiment Videos

  • PB is characterized by acinar and squamoid cell differentiation, often associated with Wnt signaling pathway alterations and Beckwith-Wiedemann syndrome.
  • Diagnosis can be challenging, with elevated alpha-fetoprotein in some cases; imaging like ultrasound and CT are useful.
  • Complete surgical resection is the primary curative treatment, with adjuvant therapies under investigation.

Conclusions:

  • Pancreatoblastoma, though rare, is considered a curable tumor when detected and treated early through complete resection.
  • Prognosis is favorable with complete resection but poorer in cases of metastasis or inoperability.
  • Increased awareness is crucial for timely diagnosis and effective management of pediatric pancreatic cancer.